| Nazwa produktu: |
Pentostatin |
| Angielska nazwa |
Pentostatin; (r)-3-(2-deoxy-beta-d-erythro-pento-furanosyl)-3,6,7,8-tetrahydroimidazo[4,5-d; (r)-3-(2-deoxy-beta-d-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)d; (r)-deoxycoformycin; (r)-rahydro; 2’dcf; 2’-deoxycoformycin; ci-825; (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol; (8R)-3-[(4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-4H-imidazo[4,5-f][1,3]diazepin-8-ol |
| MF |
C11H16N4O4 |
| Masie cząsteczkowej |
268.2691 |
| InChI |
InChI=1/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9?/m0/s1 |
| Nr CAS |
53910-25-1 |
| Struktury molekularnej |
|
| Gęstość |
1.81g/cm3 |
| Temperatura wrzenia |
646°C at 760 mmHg |
| Współczynnik załamania |
1.793 |
| Temperatura zapłonu |
344.5°C |
| Ciśnienie pary |
1.43E-17mmHg at 25°C |
| Symbole zagrożenia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
